TKNO Alpha Teknova, Inc.
$7.86▲ +10.55%
Healthcare
Other
After hours
$7.60▼ -3.31%
Oct 28, 6:49 PM ET
Volume 951.2K
Avg Volume (10D) 1.08M
Key Metrics & Fundamentals
Market Cap
$484.98M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.91 - 9.48
% vs 50 MA
2.24%
% vs 200 MA
62.15%
RSI-14
53.3
MACD Histogram
-0.0800
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$596,000
Gross Rev
$12.19M
Gross Profit
$4.89M
EBITDA
-$1.30M
COGS
$7.30M
Operating Exp
$7.78M
Operating Income
-$2.89M
EBIT
-$2.89M
Pretax Income
-$3.14M
Net Income
-$3.17M
EPS (Diluted)
-0.06
Price & Volume History
Loading chart…
Recent News

Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?
Zacks · Oct 23, 2026 7:38 AM ET

Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 21, 2026 6:30 PM ET
Top Midday Decliners
MT Newswires · Oct 21, 2026 2:00 PM ET
Top Premarket Decliners
MT Newswires · Oct 21, 2026 7:35 AM ET
Alpha Teknova Prices $40 Million Public Offering of Shares
MT Newswires · Oct 21, 2026 3:45 AM ET

Teknova Announces Pricing of $40 Million Public Offering of Common Stock
GlobeNewswire · Oct 20, 2026 10:30 PM ET
Alpha Teknova stock tumbles on public offering announcement
Investing.com · Oct 20, 2026 5:47 PM ET

Teknova Announces Proposed Public Offering of Common Stock
GlobeNewswire · Oct 20, 2026 4:02 PM ET

Teknova Announces Preliminary Third Quarter Financial Results
GlobeNewswire · Oct 20, 2026 4:01 PM ET
Alpha Teknova, Pluristyx Announce Preparation of PluriFreeze Drug Master File for US FDA Submission
MT Newswires · Oct 2, 2026 4:43 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TKNO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.